# Profiles of cannabis users and impact on cannabis cessation

**Authors:** Amy L. MacQuarrie, Caroline Brunelle

PMC · DOI: 10.1371/journal.pone.0305088 · PLOS ONE · 2024-06-11

## TL;DR

This study identifies different types of cannabis users in Canada and how their experiences with quitting vary, suggesting tailored interventions may be needed.

## Contribution

The study introduces a novel classification of cannabis users based on patterns of use and cessation attempts.

## Key findings

- Four distinct cannabis user profiles were identified using Latent Profile Analysis.
- The rapidly escalating high-risk group attempted to reduce use more frequently than others.
- Long-term high severity users were less likely to succeed in quitting compared to low-risk users.

## Abstract

Although cannabis was legalized in Canada in 2018 and is one of the most used substances in Canada, few studies have examined how individuals with different patterns of cannabis use differ in their attempts to decrease or abstain from cannabis. The current study examined how groups of cannabis users, which were formed on the basis of demographic characteristics, substance use patterns, mental health symptoms, and self-reported quality of life differed on their experiences with cannabis cessation. A sample of 147 Canadian adult participants who had attempted to decrease or quit cannabis were recruited from the community (n = 84, 57.14%) and crowdsourcing (n = 63, 42.86%). Four profiles of cannabis users emerged using a Latent Profile Analysis: low-risk (n = 62, 42.18%), rapidly escalating high-risk (n = 40, 27.21%), long-term high severity (n = 35, 23.81%), and long-term lower severity (n = 10, 6.80%). Individuals in the rapidly escalating profile had attempted to decrease their cannabis use more times compared to other profiles. More participants in the long-term high severity group found their use stayed the same or got worse after their last cessation attempt, compared to the low-risk group where more individuals indicated their use stopped. The results of the current study indicate that cannabis users differ in their attempts at reducing or ceasing cannabis use and that they may benefit from different intensity of cannabis interventions.

## Full-text entities

- **Genes:** LPA (lipoprotein(a)) [NCBI Gene 4018] {aka AK38, APOA, LP}
- **Diseases:** aggression (MESH:D010554), suicidal ideation (MESH:D001072), mental disorders (MESH:D001523), dissociation (MESH:D004213), DSM disorder (MESH:D009358), -5 (MESH:D008232), anxiety disorders (MESH:D001008), Use (MESH:D019966), sleep problems (MESH:D012893), ADHD (MESH:D001289), psychosis (MESH:D011618), symptoms (MESH:D012816), somatic symptoms (MESH:D000071896), bipolar 1 disorder (MESH:D001714), depression (MESH:D003866), repetitive thoughts and behaviours (MESH:D012090), CUD (MESH:D002189), COVID-19 (MESH:D000086382), mental (MESH:D008607), mental health (OMIM:603663), anxiety (MESH:D001007)
- **Chemicals:** substance (MESH:C012600), MDMA (MESH:D018817), cocaine (MESH:D003042), Dilaudid (MESH:D004091), Fentanyl (MESH:D005283), nitrous oxide (MESH:D009609), nicotine (MESH:D009538), Oxy (-), alcohol (MESH:D000438), Adderall (MESH:C090411), heroin (MESH:D003932), amphetamines (MESH:D000662), LSD (MESH:D008238)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11166302/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11166302/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC11166302/full.md

---
Source: https://tomesphere.com/paper/PMC11166302